Weill Cornell Medicine has received a $1.27 million grant from the United States Department of Defense to develop treatment for a rare but devastating eye condition largely affecting military personnel who suffer traumatic eye injuries in combat.
A patient living with HIV who received a blood stem cell transplant for high-risk acute myeloid leukemia has been free of the virus for 14 months after stopping HIV antiretroviral drug treatment, suggesting a cure, according to the Weill Cornell Medicine and New York-Presbyterian physician-scientists who performed the transplant and managed her care.
Cornell researchers’ concept for a mobile phone-based system to detect infectious diseases and nutritional deficiencies in saliva was awarded a $100,000 NIH Technology Accelerator Challenge prize.
The simple technique was associated with a 56% reduction in irregular heart rhythm that can lead to stroke, with no added risks, according to a Weill Cornell Medicine study.
Students living on campus have a new resource for support when they are experiencing distress, with the launch of the university’s Community Response Team at the start of this semester.
As more states legalize cannabis for medical or recreational purposes, its use during pregnancy is increasing – along with the potential forabuse or dependence.
Treatment with the amino acid arginine enhanced the effectiveness of radiation therapy in cancer patients with brain metastases in a clinical trial from investigators at Weill Cornell Medicine and Angel H. Roffo Cancer Institute.
Working with the Armenian delegation at COP26, Allison Chatrchyan aims to shape U.N. agriculture policy to reduce greenhouse gas emissions and increase carbon sequestration.
